Sirolimus topical Interactions
There are 160 drugs known to interact with sirolimus topical. Of the total drug interactions, 2 are major, 150 are moderate, and 8 are minor.
Medications known to interact with sirolimus topical
Note: Showing generic names only.
A
- adenovirus vaccine
- aliskiren
- amprenavir
- anthrax vaccine adsorbed
- aprepitant
- ashwaganda
- atazanavir
- azilsartan medoxomil
B
C
- candesartan
- captopril
- cat's claw
- ceritinib
- chikungunya vaccine, live (cvx 317)
- chloramphenicol
- cholera vaccine
- cholera vaccine, live
- ciprofloxacin
- clarithromycin
- cobicistat
- conivaptan
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizotinib
D
E
F
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- human papillomavirus vaccine
I
- idelalisib
- imatinib
- indinavir
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- irbesartan
- isavuconazonium
- itraconazole
J
K
L
- letermovir
- levoketoconazole
- lisinopril
- lonafarnib
- loncastuximab tesirine
- losartan
- lyme disease vaccine
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mibefradil
- mifepristone
- mixed respiratory vaccine
- moexipril
- mumps virus vaccine
N
O
P
- perindopril
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- posaconazole
- pralsetinib
Q
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ramipril
- ribociclib
- ritonavir
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
S
- saquinavir
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- smallpox and mpox vaccine
- smallpox vaccine
- staphage lysate (spl)
T
- talimogene laherparepvec
- telaprevir
- telithromycin
- telmisartan
- tetanus toxoid
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- trandolapril
- troleandomycin
- tucatinib
- typhoid vaccine, inactivated
- typhoid vaccine, live
V
Y
Z
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- zoster vaccine live
- zoster vaccine, recombinant
More about sirolimus topical
- sirolimus topical consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.